April 27, 2010
Dr. Mardi Gomberg-Maitland has disclosed that she has received research grant support from Actelion, Gilead, Lilly, Pfizer, Novartis, and United Therapeutics and has served as a consultant for Biomarin, Gilead, Medtronic, Millenium, and Pfizer. She does not do any promotional speaking and has received honorarium from ABcom and HealthmattersCME for CME-related events. She has a patent filed entitled, “Compositions and Methods for Treating Pulmonary Hypertension” for the use of sorafenib in pulmonary hypertension. After review of her presentation outline, these relevant financial interests/arrangements or affiliations may not have an impact on this CME activity.